Herman K, Stelmach A, Kalita A, Gruchała A
Kliniki Chirurgii Onkologicznej, Centrum Onkologii Instytutu im. M. Skłodowskiej-Curie, Oddział w Krakowie.
Wiad Lek. 1997;50 Suppl 1 Pt 2:411-6.
Stomach is the most common site of extranodal lymphoma, but lymphoma's biology differs from other types of gastric cancer. From 1982 to 1994, 80 cases of primary gastric lymphoma were treated in Cancer Center in Kraków. In order to assess the best mode of treatment the retrospective analysis of disease related parameters was performed. Sixty four patients were primary treated with surgery, and 11 with radiotherapy. After surgery 21 patients received adjuvant chemo or radiotherapy. Radical resection of tumor was done in 37 cases, in next 25 only palliative surgery was possible. There was 28 cases of lymph node metastases in resected specimens. At 5 years, the overall survival was 64.4% with the median survival of 43 months. Patients primarily treated with surgery had better 5--years survival rates compared with others (72.1% and 36.8%, respectively-p < 0.05). The chance of survival was related with the tumor grading and 5 years survived 86.5% patients with well differentiated lymphomas, and 52.6% patients with nondifferentiated tumors. There was no influence on survivals other variables as duration of symptoms, type of surgery, histological margins or adjuvant therapy. The Cox multivariate analysis showed the grading, type of first treatment and lymph node status as the only three significant factors related to survivals. The relative risk of death for nondifferentiated lymphomas was 7 times higher, than for well differentiated tumors. The primary surgery (even nonradical) of gastric lymphoma is the best mode of treatment and the grading is the most important prognostic factor influencing the survivals.
胃是结外淋巴瘤最常见的发病部位,但淋巴瘤的生物学特性与其他类型的胃癌不同。1982年至1994年期间,克拉科夫癌症中心共治疗了80例原发性胃淋巴瘤患者。为了评估最佳治疗方式,对疾病相关参数进行了回顾性分析。64例患者接受了手术为主的治疗,11例接受了放疗。手术后,21例患者接受了辅助化疗或放疗。37例患者进行了肿瘤根治性切除,另外25例仅可行姑息性手术。切除标本中有28例出现淋巴结转移。5年时,总生存率为64.4%,中位生存期为43个月。与其他患者相比,接受手术为主治疗的患者5年生存率更高(分别为72.1%和36.8%,p<0.05)。生存机会与肿瘤分级有关,高分化淋巴瘤患者5年生存率为86.5%,未分化肿瘤患者为52.6%。症状持续时间、手术类型、组织学切缘或辅助治疗等其他变量对生存率没有影响。Cox多因素分析显示,分级、初始治疗类型和淋巴结状态是与生存相关的仅有的三个显著因素。未分化淋巴瘤的死亡相对风险比高分化肿瘤高7倍。胃淋巴瘤的一期手术(即使是非根治性手术)是最佳治疗方式,分级是影响生存的最重要预后因素。